Healing & Recovery Research Peptides

The healing and recovery category covers peptides most studied in tissue-repair, angiogenesis, and extracellular-matrix research models. The best-characterized compound is BPC-157, a stable pentadecapeptide derived from a sequence in human gastric juice, first described by Sikiric and colleagues at the University of Zagreb. In a rat tendon-fibroblast model, BPC-157 dose- and time-dependently up-regulated the growth-hormone receptor at both mRNA and protein levels, a mechanism proposed to potentiate fibroblast proliferation during tendon healing.

Thymosin Beta-4 (supplied in research as TB-500) is an actin-sequestering peptide central to cell migration and angiogenesis. In a landmark full-thickness dermal-wound model, Malinda, Goldstein and Kleinman reported that Thymosin Beta-4 increased re-epithelialization by roughly 42% at day 4 and up to 61% at day 7 versus saline controls, with increased collagen deposition and new vessel formation. The copper-binding tripeptide GHK-Cu and the alpha-MSH fragment KPV round out this category as widely studied signaling and anti-inflammatory research reagents.

All compounds in this category are supplied as lyophilized reference material for in-vitro laboratory research only — not for human or veterinary use.